XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues        
Total revenues $ 83,830 $ 82,712 $ 251,806 $ 253,567
Costs of revenue (exclusive of amortization and depreciation)        
Total costs of revenue (exclusive of amortization and depreciation) 42,369 43,863 127,472 132,173
Product development 7,735 9,778 26,629 26,899
Sales and marketing 5,944 6,818 20,351 21,906
General and administrative 19,376 20,961 57,651 54,471
Amortization 6,183 6,208 21,158 17,549
Depreciation 279 297 1,079 1,392
Total expenses 81,886 87,925 254,340 254,390
Operating income (loss) 1,944 (5,213) (2,534) (823)
Other income (expense):        
Other income (expense) (376) 224 1,139 569
Interest expense (4,033) (3,071) (12,348) (8,405)
Total other expense (4,409) (2,847) (11,209) (7,836)
Loss before taxes (2,465) (8,060) (13,743) (8,659)
Income tax expense (benefit) 7,344 (4,498) 3,631 (5,344)
Net loss $ (9,809) $ (3,562) $ (17,374) $ (3,315)
Net loss per common share—basic (in dollars per share) $ (0.66) $ (0.24) $ (1.17) $ (0.23)
Net loss per common share—diluted (in dollars per share) $ (0.66) $ (0.24) $ (1.17) $ (0.23)
Weighted average shares outstanding used in per common share computations:        
Basic (in shares) 14,323 14,205 14,290 14,181
Diluted (in shares) 14,323 14,205 14,290 14,181
Financial Health        
Revenues        
Total revenues $ 54,271 $ 46,582 $ 161,417 $ 142,973
Costs of revenue (exclusive of amortization and depreciation)        
Total costs of revenue (exclusive of amortization and depreciation) 29,185 27,159 89,051 81,461
Patient Care        
Revenues        
Total revenues 29,559 36,130 90,389 110,594
Costs of revenue (exclusive of amortization and depreciation)        
Total costs of revenue (exclusive of amortization and depreciation) $ 13,184 $ 16,704 $ 38,421 $ 50,712